PD-1 Modulates Radiation-Induced Cardiac Toxicity through Cytotoxic T Lymphocytes.
PD-1 Modulates Radiation-Induced Cardiac Toxicity through Cytotoxic T Lymphocytes.
复制标题
PD-1通过细胞毒性T淋巴细胞调节辐射诱导的心脏毒性。
DOI:
10.1016/j.jtho.2017.12.002
复制
发表时间:
2018-04
影响因子:
20.4
通讯作者:
Lu, Bo
中科院分区:
文献类型:
--
作者:
Du, Shisuo;Zhou, Lin;Alexander, Gregory S.;Park, Kyewon;Yang, Lifeng;Wang, Nadan;Zaorsky, Nicholas G.;Ma, Xinliang;Wang, Yajing;Dicker, Adam P.;Lu, Bo
Combined immune checkpoint blockade has led to rare autoimmune complications, such as fatal myocarditis. Recent approvals of several anti–programmed death 1 (anti–PD-1) drugs for lung cancer treatment prompted ongoing clinical trials that directly combine PD-1 inhibitors with thoracic radiotherapy for locally advanced lung cancer. Overlapping toxicities from either modality have the potential to increase the risk for radiation-induced cardiotoxicity (RICT), which is well documented among patients with Hodgkin’s disease and breast cancer. To investigate cardiotoxicity without the compounding pulmonary toxicity from thoracic radiotherapy, we developed a technique to deliver cardiac irradiation (CIR) in a mouse model concurrently with PD-1 blockade to determine the presence of cardiac toxicity by using physiological testing and mortality as end points along with histological analysis. We observed an acute mortality of 30% within 2 weeks after CIR plus anti–PD-1 antibody compared with 0% from CIR plus immunoglobulin G (p = 0.023). Physiological testing demonstrated a reduced left ventricular ejection fraction (p < 0.01) by echocardiogram. Tissue analyses revealed increased immune cell infiltrates within cardiac tissue. Depletion of CD8-positive lymphocytes with anti-CD8 antibody reversed the acute mortality, suggesting that the toxicity is CD8-positive cell-mediated. To validate these findings using a clinically relevant fractionated radiotherapy regimen, we repeated the study by delivering five daily fractions of 6 Gy. Similar mortality, cardiac dysfunction, and histological changes were observed in mice receiving fractionated radiotherapy with concurrent anti–PD-1 therapy. This study provides strong preclinical evidence that radiation-induced cardiotoxicity is modulated by the PD-1 axis and that PD-1 blockade should be administered with careful radiotherapy planning with an effort of reducing cardiac dose.
登录
查看更多内容
影响因子:
51.1
作者:
Bradley, Jeffrey D.;Paulus, Rebecca;Komaki, Ritsuko;Masters, Gregory;Blumenschein, George;Schild, Steven;Bogart, Jeffrey;Hu, Chen;Forster, Kenneth;Magliocco, Anthony;Kavadi, Vivek;Garces, Yolanda I.;Narayan, Samir;Iyengar, Puneeth;Robinson, Cliff;Wynn, Raymond B.;Koprowski, Christopher;Meng, Joanne;Beitler, Jonathan;Gaur, Rakesh;Curran, Walter, Jr.;Choy, Hak
通讯作者:
Choy, Hak
DOI:
10.1056/nejmoa1504030
发表时间:
2015-07-02
期刊:
The New England journal of medicine
影响因子:
--
作者:
Larkin J;Chiarion-Sileni V;Gonzalez R;Grob JJ;Cowey CL;Lao CD;Schadendorf D;Dummer R;Smylie M;Rutkowski P;Ferrucci PF;Hill A;Wagstaff J;Carlino MS;Haanen JB;Maio M;Marquez-Rodas I;McArthur GA;Ascierto PA;Long GV;Callahan MK;Postow MA;Grossmann K;Sznol M;Dreno B;Bastholt L;Yang A;Rollin LM;Horak C;Hodi FS;Wolchok JD
通讯作者:
Wolchok JD
影响因子:
5.4
作者:
Fu, Guoqiang;Cao, Yizhan;Zheng, Qiangsun
通讯作者:
Zheng, Qiangsun
DOI:
10.1097/jto.0000000000000306
发表时间:
2014-10
期刊:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
影响因子:
--
作者:
Gomez DR;Yusuf SW;Munsell MF;Welsh JW;Liao Z;Lin SH;Pan HY;Chang JY;Komaki R;Cox JD;McAleer MF;Grosshans DR
通讯作者:
Grosshans DR
影响因子:
5.9
作者:
BROSIUS, FC;WALLER, BF;ROBERTS, WC
通讯作者:
ROBERTS, WC